Project description:<p>Lipids, fundamental constituents of cell membranes, cellular energy carriers, and signaling molecules, play a pivotal role in the interaction between pathogens and hosts. During microbial infections, lipids not only fuel the activation of the immune system but also, acting as signaling molecules, participate in crucial biological processes such as inflammation initiation, macrophage polarization, and adaptive immune regulation. Serving as the primary reservoirs of neutral lipids within host cells, lipid droplets (LDs) function as the regulatory hub for cellular lipid metabolism and immune responses. Following lipopolysaccharide (LPS) stimulation, mouse (Mus musculus) deploy a diverse array of proteins, including those with antiviral and antibacterial activities, along with regulatory proteins of the immune system, onto immune cell lipid droplets. This action suppresses the interaction between LDs and mitochondria, thereby coordinates host metabolic and immune reactions to combating infections. How LDs in fish are reprogramed by bacterial infections in aspects of their metabolisms and anti-infection reaction remains insufficiently elucidated.</p><p>Employing turbot (Scophthalmus maximus) as the model organism, this study employs comparative proteomics to systematically screen alterations in the protein composition of liver LDs pre- and post- infection. This endeavor preliminarily illuminates the metabolic and immune-regulatory functions that LDs exhibit in response to pathogenic bacterial incursions. It was observed that the LDs of turbot contain a substantial amount of histones with antibacterial properties. Post bacterial infection, the liver of turbot orchestrates the recruitment of a plethora of proteins, essential for purine nucleotide metabolism, fatty acid oxidation, oxidative phosphorylation and ADP/ATP turnover, onto LDs. This orchestrated effort culminates in the reprogramming of metabolic pathways to counteract bacterial invasions, signifying the extensive involvement of fish LDs in the regulatory nexus of anti-infective immune responses. Furthermore, it was observed that the absence of the T3SS in the Edwardsiella piscicida mutants leads to marked alterations in the levels of ferroptosis related proteins, such as ACSL4 and FSP1, on LDs. This implies that LDs may mediate bactericidal activities either through the direct recruitment of antimicrobial proteins or peptides or by modulating cellular ferroptosis to activate anti-infective immune responses. Correspondingly, unsaturated fatty acids (UFAs) within the host can attenuate bacterial virulence by directly binding to the central regulatory protein EsrC, thereby suppressing the expression of the T3SS and impairing bacterial virulence.</p><p>To counteract LD and lipid-mediated antibacterial immunity, pathogenic microorganisms have evolved various mechanisms to interfere with host LD metabolism. The genes related to LD tolerance were systematically screened in fish pathogen E. piscicida with Tn-seq technology, and four genes such as ETAE_2018, flgH, evpG, and uxaB were identified as those related to bacterial LD tolerance. The notable effect of EvpG, a component of the T6SS, implied that E. piscicida might actively modulate host LD metabolism through a virulence secretion system. Systematic screening reveals that E. piscicida could actively inhibit the accumulation of LDs in host cells during infection through the T3SS effectors, EseO (ETAE_1604) and EseP (ETAE_3282). Biochemical experiments further indicate that EseO, by binding its 10th tyrosine residue with the amino acids of the fatty acid binding protein 5 (FABP5) in the small hydrophobic channel domain, influences the binding and transportation capacity of FABP5 for fatty acids. On the other hand, EseP, by binding its 4th phenylalanine residue with the 236th serine residue of fatty acid synthase (FASN), influences fatty acid de novo synthesis.</p><p>Transcriptomic and lipidomic data indicate that the equilibrium of host LD metabolism and immune responses is disrupted by EseO and EseP in E. piscicida. These effectors not only regulate the pathways related to cholesterol metabolism, fatty acid biosynthesis, and elongation, but also directly impact host immune and inflammatory responses through MAPK and JAK-STAT signaling pathways. Furthermore, EseO can modulate ubiquinone biosynthesis and inhibit the accumulation of reactive oxygen species and ferrous ions, as well as lipid peroxidation during infection, thereby inhibiting the bactericidal function mediated by the host ferroptosis pathway. By reducing the accumulation of LDs, EseO and EseP suppress the synthesis and secretion of prostaglandin E2 (PGE2) and the cytotoxicity mediated by cation antimicrobial peptides (CAMPs) on LDs, to consequently promote the survival and replication of E. piscicida within the host.</p><p>Finally, the genes related to copper ion tolerance in E. piscicida were screened with Tn-seq technology. Confronted with copper ion stress, E. piscicida necessitates a large-scale reprogramming of metabolism and the expression of genes associated with antioxidative stress responses to counteract the toxicity of copper ions. A novel transcriptional regulator, CorR, was identified to respond to copper ions and regulate the expression of the copper efflux pump, CopA, thus to enhance the copper ion tolerance and environmental survival capability of E. piscicida. The related copper ion tolerance pathway might play a crucial role in countering host cell copper metabolism-mediated anti-infective immune responses during infection.</p><p>This study primarily dissects the functionality of LDs in the pathogenic-host interaction mediated by E. piscicida, elucidating a novel mechanism through which pathogenic microorganisms manipulate host lipid metabolism via T3SS (also T6SS) to inhibit LD accumulation. It deepens our understanding of the tug-of-war between lipid-mediated pathogenic-host infection and anti-infective responses, and further reveals that LDs serve as a pivotal link between metabolism and the immune system in anti-infective immunity. EseO, EseP, and their derivatives may provide new candidate drug molecules for the treatment of lipid metabolism-related diseases in humans and animals, and also offer insights into the development of novel aquaculture vaccines and disease control strategies.</p>
2025-07-05 | MTBLS12678 | MetaboLights